A. V. Vreckem

Taxol (T) versus doxorubicin (D) as first-line chemotherapy (CT) in advanced breast cancer (ABC): An EORTC randomized study with crossover

M. Piccart, R. Paridaens, P. Bruning, 1997 .

Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.

L. Seymour, F. Shepherd, M. Tonato, 2004, Lung cancer.

Mitomycin C and Vinblastine in combination with Amifostine in metastatic breast cancer

M. Piccart, A. Awada, J. Kerger, 1997, Supportive Care in Cancer.

347 Steroids do reduce the severity and delay the onset of docetaxel (DXT) induced fluid retention: Final results of a randomized trial of the EORTC investigational drug branch for breast cancer (IDBBC)

J. Klijn, M. Piccart, M. Nooij, 1995 .

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over.

J. Klijn, M. Piccart, R. Paridaens, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18

L. Seymour, F. Shepherd, M. Tonato, 2001 .

EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer

J. Klijn, M. Piccart, R. Paridaens, 2000, Breast Cancer Research and Treatment.

Study of excretion balance, metabolism and protein binding of Caradiolabelled Taxotere (TXT) (RP56976, NSC628503) in cancer patients.

M. Piccart-Gebhart, E. Tomiak, J. Kerger, 1993 .

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.

M. van Glabbeke, J. Klijn, M. Nooij, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.